| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 1,248,700 | 1,222,800 | 1,201,100 | 1,386,500 | | Cost of Revenue | 807,500 | 801,000 | 785,700 | 893,300 | | | Gross Profit | 441,200 | 421,800 | 415,400 | 493,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 333,600 | 332,600 | 317,800 | 328,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 107,600 | 89,200 | 97,600 | 165,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 2,600 | | Earnings Before Interest And Taxes | 103,900 | 89,200 | 97,600 | 167,800 | | Interest Expense | (2,100) | 1,300 | 800 | 3,500 | | Income Before Tax | 106,000 | 87,900 | 96,800 | 164,300 | | Income Tax Expense | 37,800 | 31,000 | 36,400 | 59,100 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 68,200 | 56,900 | 60,400 | 105,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 68,200 | 56,900 | 60,400 | 105,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $68,200 | $56,900 | $60,400 | $105,200 |
|
0.03% Nasdaq 
Income Statement
